Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 88889-14-9
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
88889-14-9 |
Appearance:: |
White Crystalline Solid |
Molecular Formula:: |
C30H45NNaO7P |
Molecular Weight:: |
585.64400 |
EINECS NO:: |
620-449-1 |
MDL NO:: |
MFCD00865785 |
CAS NO:: |
88889-14-9 |
Appearance:: |
White Crystalline Solid |
Molecular Formula:: |
C30H45NNaO7P |
Molecular Weight:: |
585.64400 |
EINECS NO:: |
620-449-1 |
MDL NO:: |
MFCD00865785 |
Product Description:
Product Name: Fosinopril sodium CAS NO: 88889-14-9
Synonyms:
Fosinopril sodium;
sodium,(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate;
Chemical & Physical Properties:
Appearance: White crystalline solid
Assay :≥99.00%
Density: 1.173
Boiling Point: 705.7℃at 760 mmHg
Melting Point: 196-198℃
Storage Condition: -20℃ Freezer
Safety Information:
HS Code: 2933990090
WGK Germany: 3
A phosphinic acid containing angiotensin converting enzyme (ACE) inhibitor. Antihypertensive. Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension and some types of chronic heart failure.Target: ACEFosinopril is a phosphinic acid-containing ester prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is rapidly hydrolyzed to fosinoprilat, its principle active metabolite. Fosinoprilat inhibits ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Fosinopril may be used to treat mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure, and to slow the rate of progression of renal disease in hypertensive individuals with diabetes mellitus and microalbuminuria or overt nephropathy.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.